Beruflich Dokumente
Kultur Dokumente
Search
Collections
Journals
About
Contact us
My IOPscience
Synthesis of water-dispersible zinc oxide quantum dots with antibacterial activity and low
cytotoxicity for cell labeling
This content has been downloaded from IOPscience. Please scroll down to see the full text.
2013 Nanotechnology 24 475102
(http://iopscience.iop.org/0957-4484/24/47/475102)
View the table of contents for this issue, or go to the journal homepage for more
Download details:
IP Address: 129.174.21.5
This content was downloaded on 06/06/2014 at 17:43
IOP PUBLISHING
NANOTECHNOLOGY
doi:10.1088/0957-4484/24/47/475102
Institute of Polymer Science and Engineering, National Taiwan University, Taipei 10617,
Taiwan, Republic of China
2
Research Center for Developmental Biology and Regenerative Medicine, National Taiwan University,
Taipei 10617, Taiwan, Republic of China
3
Department of Physics, MTSE Program, New Jersey Institute of Technology, NJ 07102, USA
4
Super Learning International LLC, NJ 07869, USA
5
School of Chemical Engineering, Chonbuk National University, Jeonju 561-756, Republic of Korea
E-mail: shhsu@ntu.edu.tw and dslee@jbnu.ac.kr
1. Introduction
S-H Hsu et al
2. Experimental procedure
2.1. Preparation of water-dispersible ZnO QDs
2 g of Zn(CH3 COO)2 2H2 O, 0.12 g of hydrolyzed
hexahydro-4-methyl phthalic anhydride (HMA) ([HMA]/
[Zn2+ ] = 0.07) and 120 g of methanol were incorporated
into a reactor. 80 g of triethylamine (TEA) was then added
to the mixture under stirring and the reaction was carried
out for four days. After the synthesis, ZnO NPs (denoted
2
S-H Hsu et al
Figure 1. (A) Zn(CH3 COO)2 2H2 O and HMA were used for synthesis of ZnO QDs in methanol. The ZnOHMA QDs were then
precipitated by adding heptane, washed, and redispersed in methanol to get 0.5% ZnOHMA QD dispersions. (B) To prepare
water-dispersible ZnO QDs, either type of the two PEG molecules was added to the ZnOHMA QDs solution. The water-dispersible QDs
generated were each abbreviated as ZnO-S-PEG-NH2 QDs and ZnO-NH-PEG-NH2 .
were re-inoculated onto the plate count agar. The plates were
cultivated at 35 C for 24 h. The numbers of the bacterial
colony were transformed into logarithms of base 10 (log10 ) to
show the antibacterial activity. All experiments were repeated
4 times.
S-H Hsu et al
S-H Hsu et al
Figure 2. High-resolution TEM images of ZnOHMA QDs, ZnO-S-PEG-NH2 QDs, and ZnO-NH-PEG-NH2 QDs. On the right upper
panel of each image, the enlarged TEM image reveals the crystalline structure of QDs.
S-H Hsu et al
Figure 3. (A) The zeta potential and (B) hydrodynamic diameter of ZnO QDs. (C) FTIR spectra of ZnOHMA QDs, ZnO-S-PEG-NH2
QDs, and ZnO-NH-PEG-NH2 QDs. (D) Thermal gravimetric analysis of ZnOHMA QDs, ZnO-S-PEG-NH2 QDs, and ZnO-NH-PEG-NH2
QDs.
The FTIR spectra of ZnOHMA QDs and waterdispersible ZnO QDs are displayed in figure 3(C). The
characteristic absorption band at 1415 cm1 (CO stretching)
was observed for ZnOHMA. After PEG conjugation,
the absorption band at 1415 cm1 disappeared. Instead,
absorption bands ranging from 1000 to 1250 cm1 were
observed, which was attributed to the amine group (CN) in
the structure of PEG. A new absorption peak at 1657 cm1
showed up in the spectrum of ZnO-NH-PEG-NH2 , which
was assigned to the amide I band. The appearance of this
new peak represented a conjugation between the carboxylic
group derived from ZnOHMA and the amine group on
NH2 -PEG-NH2 via EDC [41, 42]. Comparing the spectra
of ZnOHMA and ZnO-S-PEG-NH2 , the specific adsorption
bands at 14001600 cm1 for ZnOHMA disappeared in
ZnO-S-PEG-NH2 . This suggested that SH-PEG-NH2 may
directly bind with ZnO QDs by competing with HMA for
binding sites.
The corresponding TGA curves are shown in figure 3(D).
A weight loss of 27.4% at 500 C for ZnOHMA QDs
was ascribed to the HMA on the surface of the QDs.
The corresponding weight loss of ZnO-S-PEG-NH2 and
ZnO-NH-PEG-NH2 was 64.6% and 51.8% respectively. The
per cent weight loss at high temperature represented the
organic fraction (HMA or PEG) of the ZnO QDs. The
greater weight loss (or organic fraction) of ZnO-S-PEG-NH2
may be attributed to the molecular weight of the stabilizer
S-H Hsu et al
Figure 4. (A) The antibacterial efficacy of ZnOHMA QDs, ZnO-S-PEG-NH2 QDs, and ZnO-NH-PEG-NH2 QDs. (B)(D) The viability
of HepG2, MC3T3-E1, and ADAS cells exposed to ZnO-S-PEG-NH2 QDs and ZnO-NH-PEG-NH2 QDs of different concentrations for
24 h.
Many investigations about the cytotoxicity and antibacterial properties of silver NPs have been published. In spite of
their remarkable antibacterial properties, silver NPs demonstrate mitochondrial dysfunction and induction of ROS which
in turn set off DNA damage and chromosomal aberrations.
Future applications of silver NPs as an antiproliferative agent
could be limited by the fact that they are equally toxic to
normal cells [44]. In comparison, the major advantage of ZnO
QDs is the biocompatibility and low cytotoxicity, especially
for human stem cells.
S-H Hsu et al
Figure 5. ROS levels for HepG2, MC3T3-E1, and ADAS cells exposed to ZnO-S-PEG-NH2 QDs and ZnO-NH-PEG-NH2 QDs at the
concentration of 30 ppm for 2 h.
S-H Hsu et al
4. Conclusion
S-H Hsu et al
Figure 7. (A) The expression of stemness marker genes Sox2 and Oct4 for ADAS cultured for 24 h and then challenged with
water-dispersible ZnO QDs (30 ppm) for 36 h, analyzed by the real-time RT-PCR. p < 0.05 among the indicated groups. (B)(D) The gene
expression of Sox9, Runx2, and PPAR 2 for ADAS labeled with water-dispersible ZnO QDs each after chondrogenic, osteogenic, and
adipogenic induction for two weeks. p < 0.05 among the indicated groups. These data suggest that the stemness and multipotency of
ADAS may not be adversely affected by QD labeling.
Figure 8. (A) The oxygen consumption rate (OCR) and (B) extracellular acidification rate (ECAR) of ADAS upon exposure to
ZnO-S-PEG-NH2 QDs at 30 and 60 ppm. In the plots, the challenge was given at 35 min (shown as the dotted line) and last for a period of
85 min (end point: 120 min).
Acknowledgments
References
[1] Iyer G, Michalet X, Chang Y-P, Pinaud F F, Matyas S E,
Payne G and Weiss S 2008 Nano Lett. 8 4618
[2] Jayagopal A, Su Y R, Blakemore J L, Linton M F, Fazio S and
Haselton F R 2009 Nanotechnology 20 165102
[3] Marks K M and Nolan G P 2006 Nature Methods 3 591
[4] Kirchner C, Liedl T, Kudera S, Pellegrino T, Munoz Javier A,
Gaub H E, Stolzle S, Fertig N and Parak W J 2004 Nano
Lett. 5 331
S-H Hsu et al
11